Contributor Disclosures for Anemia of Prematurity

Role Name Disclosure Details Author  Charles F Potter, MD, Assistant Professor, Department of Pediatrics, Division of Neonatology, Southern Illinois University School of Medicine; Director of Newborn Medicine, Memorial Medical Center Nothing to disclose Details Coauthor  W Michael Southgate, MD, Medical Director of Neonatal Intensive Care Unit, Associate Professor, Department of Pediatrics, Division of Neonatology, Medical University of South Carolina Nothing to disclose Details Medical Editor  Scott S MacGilvray, MD, Associate Professor, Department of Pediatrics, East Carolina University School of Medicine MedImmune Speakers Bureau Details Pharmacy Editor  Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc Pfizer Inc Avanir Pharma Details Managing Editor  Brian S Carter, MD, FAAP, Professor of Pediatrics, Department of Pediatrics, Division of Neonatology, Vanderbilt University School of Medicine; Co-director, Pediatric Advance Comfort Team, Vanderbilt Children's Hospital Nothing to disclose Details CME Editor  Carol L Wagner, MD, Professor of Pediatrics, Medical University of South Carolina Nothing to disclose Details Chief Editor  Neil N Finer, MD, Professor, Department of Pediatrics, University of California at San Diego School of Medicine; Program Director, Division of Neonatology, University of California San Diego Medical Center Nothing to disclose Details Contributor Disclosure Contributor: Contributor Disclosure: Charles F Potter, Author  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: W Michael Southgate, Coauthor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Scott MacGilvray  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** MedImmune Speakers Bureau Honoraria Speaking and teaching   Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Mary L Windle  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Pfizer Inc Stock Investment from broker recommendation   Avanir Pharma Stock Investment from broker recommendation   Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Brian S Carter  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication None Contributor Disclosure Contributor: Contributor Disclosure: Carol L Wagner, CME Editor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Neil N Finer, Chief Editor  The contributor discloses no conflict of interest.